Literature DB >> 23557792

Effect of dark chocolate on renal tissue oxygenation as measured by BOLD-MRI in healthy volunteers.

Menno Pruijm, Lucie Hofmann, Julie Charollais-Thoenig, Valentina Forni, Marc Maillard, Andrew Coristine, Matthias Stuber, Michel Burnier, Bruno Vogt.   

Abstract

BACKGROUND: Cocoa is rich in flavonoids, has anti-oxidative properties and increases the bioavailability of nitric oxide (NO). Adequate renal tissue oxygenation is crucial for the maintenance of renal function. The goal of this study was to investigate the effect of cocoa-rich dark chocolate (DC) on renal tissue oxygenation in humans, as compared to flavonoid-poor white chocolate (WC).
METHODS: Ten healthy volunteers with preserved kidney function (mean age ± SD 35 ± 12 years, 70% women, BMI 21 ± 3 kg/m2) underwent blood oxygenation level-dependent magnetic resonance imaging (BOLD-MRI) before and 2 hours after the ingestion of 1 g/kg of DC (70% cocoa). Renal tissue oxygenation was determined by the measurement of R2* maps on 4 coronal slices covering both kidneys. The mean R2* (= 1/T2*) values in the medulla and cortex were calculated, a low R2* indicating high tissue oxygenation. Eight participants also underwent BOLD-MRI at least 1 week later, before and 2 hours after the intake of 1 g/kg WC.
RESULTS: The mean medullary R2* was lower after DC intake compared to baseline (28.2 ± 1.3 s-1 vs. 29.6 ± 1.3 s-1, p = 0.04), whereas cortical and medullary R2* values did not change after WC intake. The change in medullary R2* correlated with the level of circulating (epi)catechines, metabolites of flavonoids (r = 0.74, p = 0.037), and was independent of plasma renin activity.
CONCLUSION: This study suggests for the first time an increase of renal medullary oxygenation after intake of dark chocolate. Whether this is linked to flavonoid-induced changes in renal perfusion or oxygen consumption, and whether cocoa has potentially renoprotective properties, merits further study.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23557792     DOI: 10.5414/CN107897

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  7 in total

1.  The Kidney Dysfunction Epidemic, Part 2: Intervention.

Authors:  Joseph Pizzorno
Journal:  Integr Med (Encinitas)       Date:  2016-03

2.  Assessment of Perfusion and Oxygenation of the Human Renal Cortex and Medulla by Quantitative MRI during Handgrip Exercise.

Authors:  Bryan Thomas Haddock; Susan T Francis; Henrik B W Larsson; Ulrik B Andersen
Journal:  J Am Soc Nephrol       Date:  2018-09-11       Impact factor: 10.121

3.  Effect of cocoa butter and sunflower oil supplementation on performance, immunoglobulin, and antioxidant vitamin status of rats.

Authors:  Ebru Yıldırım; Miyase Cınar; Ilkay Yalçınkaya; Hüsamettin Ekici; Nurgül Atmaca; Enes Güncüm
Journal:  Biomed Res Int       Date:  2014-07-16       Impact factor: 3.411

4.  Effects of the SGLT-2 Inhibitor Empagliflozin on Renal Tissue Oxygenation in Non-Diabetic Subjects: A Randomized, Double-Blind, Placebo-Controlled Study Protocol.

Authors:  Marie-Eve Muller; Menno Pruijm; Olivier Bonny; Michel Burnier; Anne Zanchi
Journal:  Adv Ther       Date:  2018-05-25       Impact factor: 3.845

5.  Sub-Chronic Consumption of Dark Chocolate Enhances Cognitive Function and Releases Nerve Growth Factors: A Parallel-Group Randomized Trial.

Authors:  Eri Sumiyoshi; Kentaro Matsuzaki; Naotoshi Sugimoto; Yoko Tanabe; Toshiko Hara; Masanori Katakura; Mayumi Miyamoto; Seiji Mishima; Osamu Shido
Journal:  Nutrients       Date:  2019-11-16       Impact factor: 5.717

Review 6.  Chocolate, "Food of the Gods": History, Science, and Human Health.

Authors:  Maria Teresa Montagna; Giusy Diella; Francesco Triggiano; Giusy Rita Caponio; Osvalda De Giglio; Giuseppina Caggiano; Agostino Di Ciaula; Piero Portincasa
Journal:  Int J Environ Res Public Health       Date:  2019-12-06       Impact factor: 3.390

7.  Acute and Chronic Effects of SGLT2 Inhibitor Empagliflozin on Renal Oxygenation and Blood Pressure Control in Nondiabetic Normotensive Subjects: A Randomized, Placebo-Controlled Trial.

Authors:  Anne Zanchi; Michel Burnier; Marie-Eve Muller; Arlène Ghajarzadeh-Wurzner; Marc Maillard; Nicolas Loncle; Bastien Milani; Nathalie Dufour; Olivier Bonny; Menno Pruijm
Journal:  J Am Heart Assoc       Date:  2020-06-20       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.